Hopital l Archet 2; Ginestriere, Service de; Dermatologie

Nice 06200

0 studies enrolling now · 2 studies all time

What they study most

Advanced BRAFV600 Wild-type Melanoma, Atopic Dermatitis

Studies at this site

• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early
• A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis — Completed